From: Monitoring adherence to guidelines of antibiotic use in pediatric pneumonia: the MAREA study
 | Children with pneumonia (phase I + II) (No. 400 prescriptions) | Pre-educational course (phase I) (No. 246 prescriptions) | Post-educational course (phase II) (No. 154 prescriptions) | P value |
---|---|---|---|---|
Single parameter appropriateness | ||||
  Indication [No. (%)] | 400 (100.00) | – | – | – |
  Choice of antibiotic [No. (%)] | 370 (92.50) | 224 (91.06) | 146 (94.81) | .17 |
  Duration [No. (%)] | 242/389a (62.21) | 143/236a (60.59) | 99/153a (64.71) | .41 |
  Dose [No. (%)] | 324/399a (81.20) | 198/245a (80.82) | 126 (81.82) | .80 |
Global appropriateness [No. (%)] | 175/389a (44.99) | 103/236 (43.64) | 72/153 (47.06) | .51 |